(Reuters) -Researchers monitoring the brain activity of a patient with a severe binge-eating problem reported that Eli Lilly's GLP-1 weight-loss drug appeared to temporarily suppress food-craving ​signals in the "reward center" of the brain. These are the first direct measurements of brain activity ‌in a person receiving tirzepatide, sold as Mounjaro for diabetes and Zepbound for weight loss, shedding light on the treatment's impact on so-called ‌food noise.

The monetary world is always developing, and Album rates can change because of different financial variables. Safeguarding your speculations during

Dental nervousness, or dengoodhobia, is a typical trepidation that keeps numerous from getting the fundamental dental consideration. Keeping away from the dental specialist